| Literature DB >> 27898008 |
Haonan Zhou1, Pengjie Zhang2, Zhiguo Hou3, Jiabin Xie4, Yuming Wang5, Bin Yang6, Yanyan Xu7, Yubo Li8.
Abstract
Radix Aconiti, a classic traditional Chinese medicine (TCM), has been widely used throughout China for disease treatment due to its various pharmacological activities, such as anti-inflammatory, cardiotonic, and analgesic effects. However, improper use of Radix Aconiti often generated severe acute toxicity. Currently, research on the toxic substances of Radix Aconiti is not rare. In our previous study, acute toxic biomarkers of Radix Aconiti have been found. However, few studies were available to find the relationships between these endogenous biomarkers and exogenous toxic substances. Therefore, in this study, toxic substances of Radix Aconiti have been found using UPLC-Q-TOF-MS technology. Then, we used biochemical indicators as a bridge to find the relationships between biomarkers and toxic substances of Radix Aconiti through Pearson correlation analysis and canonical correlation analysis (CCA). Finally, the CCA results showed that LysoPC(22:5) is related to 14-acetyl-talatisamine, mesaconitine, talatisamine and deoxyaconitine in varying degrees; l-acetylcarnitine is negatively correlated with deoxyaconitine and demethyl-14-acetylkaracoline; shikimic acid has a good correlation with karacoline, demethyl-14-acetylkaracoline and deoxyaconitine; and valine is correlated with talatisamine and deoxyaconitine. Research on these relationships provides an innovative way to interpret the toxic mechanism of traditional Chinese medicine, and plays a positive role in the overall study of TCM toxicity.Entities:
Keywords: Radix Aconiti; acute toxicity; biomarkers; corresponding relationships; toxic substances
Mesh:
Substances:
Year: 2016 PMID: 27898008 PMCID: PMC6273418 DOI: 10.3390/molecules21121623
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Effect of different concentrations of Radix Aconiti ethanol extract groups on various biochemical parameters in rats. Significant difference from control: * p < 0.05, ** p < 0.01. NS: Normal Saline; A: 2 g/kg ethanol extraction; B: 5 g/kg ethanol extraction; C: 10 g/kg ethanol extraction.
Figure 2Pathological examination of heart, kidney and liver tissue after the administration of Radix Aconiti ethanol extraction. NS: Normal Saline; Low Dose: 2 g/kg ethanol extraction; Middle Dose: 5 g/kg ethanol extraction; High Dose: 10 g/kg ethanol extraction (10× magnification).
Mass measurement for exogenous metabolites of Radix Aconiti ethanol extraction.
| Metabolites | TR (min) | Formula | MS/MS | |
|---|---|---|---|---|
| Karacoline | 1.77 | 378.2643 | C22H35NO4 | 378.3, 360.2, 332.2, 328.2, 310.2 |
| Karacolidine | 1.82 | 394.2625 | C22H35NO5 | 394.3, 376.2, 358.2, 344.2, 340.2, 326.2 |
| Demethyl-14-acetylkaracoline | 3.04 | 406.2597 | C23H35NO5 | 406.3, 388.2, 356.2, 338.2 |
| Talatisamine | 6.05 | 422.2967 | C24H39NO5 | 422.3, 390.3, 372.3, 358.2, 340.2 |
| 14-acetyltalatisamine | 9.4 | 464.3051 | C26H41NO6 | 464.3, 432.3, 400.3, 372.2 |
| Pengshenine A | 1.28 | 436.2327 | C24H37NO6 | 436.2 |
| Mesaconitine | 16.82 | 632.3134 | C33H45NO11 | 632.3, 600.3, 582.3, 572.3, 540.3 |
| Deoxyaconitine | 18.66 | 630.3338 | C34H47NO10 | 630.3, 598.3, 570.3, 538.3, 506.3 |
Figure 3The variation trends of eight serum ingredients’ relative contents (peak area intensities) in different concentrations of Radix Aconiti ethanol extraction groups. A: 2 g/kg ethanol extraction; B: 5 g/kg ethanol extraction; C: 10 g/kg ethanol extraction.
The correlation of biochemical indicators and exogenous components.
| Metabolites | CK | LDH | ALT | AST | Scr | Urea |
|---|---|---|---|---|---|---|
| karacoline | 0.858 | 0.843 | 0.986 * | 0.810 | 0.916 | 0.888 |
| karacolidine | 0.709 | 0.692 | 0.950 * | 0.761 | 0.876 | 0.763 |
| demethyl-14-acetylkaracoline | 0.987 * | 0.985 | 0.942 | 0.966 * | 0.979 * | 0.997 ** |
| pengshenine A | 0.922 | 0.911 | 0.910 | 0.765 | 0.850 | 0.921 |
| talatisamine | 0.984 * | 0.978 * | 0.954 * | 0.919 | 0.959 * | 0.992 ** |
| 14-acetyl-talatisamine | 0.990 * | 0.985 * | 0.939 | 0.908 | 0.944 | 0.993 ** |
| mesaconitine | 0.960 * | 0.953 * | 0.888 | 0.805 | 0.861 | 0.951 * |
| deoxyaconitine | 0.967 * | 0.958 * | 0.950 * | 0.865 | 0.925 | 0.972 * |
*: Correlation is significant (p < 0.05) **: Correlation is highly significant (p < 0.01).
Figure 4The variation trends of biomarkers’ relative contents (peak area intensities) in Radix Aconiti ethanol extraction groups with different doses. Significant difference from control: * p < 0.05, ** p < 0.01. NS: Normal Saline; A: 2 g/kg ethanol extraction; B: 5 g/kg ethanol extraction; C: 10 g/kg ethanol extraction.
The correlation of biochemical indicators and endogenous biomarkers.
| Metabolites | CK | LDH | ALT | AST | Scr | Urea |
|---|---|---|---|---|---|---|
| valine | −0.963 * | −0.954 * | −0.949 | −0.856 | −0.920 | −0.968 * |
| −0.950 * | −0.942 * | −0.987 * | −0.907 | −0.968 * | −0.970 * | |
| LysoPC(22: 5) | −0.983 * | −0.978 * | −0.915 | −0.866 | −0.908 | −0.980 * |
| shikimic acid | 0.974 * | 0.969 * | 0.881 | 0.828 | 0.870 | 0.964 * |
*: Correlation is significant (p< 0.05).
The normalization coefficients of acute toxic biomarkers and toxic substances.
| Toxic Substances | Biomarkers | |||
|---|---|---|---|---|
| y1 | y2 | y3 | y4 | |
| x1 | 0.403 | −0.191 | 1.270 | 0.136 |
| x2 | −0.287 | −0.636 | 0.658 | −0.229 |
| x3 | −0.587 | −0.223 | 0.224 | −0.558 |
| x4 | −1.111 | 0.097 | 0.427 | −0.309 |
| x5 | 1.444 | −0.258 | −0.353 | −0.138 |
| x6 | 0.585 | −0.555 | −0.832 | 0.867 |
x1: karacoline; x2: demethyl-14-acetylkaracoline; x3: talatisamine; x4: 14-acetyl-talatisamine; x5: mesaconitine; x6: deoxyaconitine; y1: LysoPC(22: 5); y2: l-acetylcarnitine; y3: shikimic acid; y4: valine.
Group, dose, administration mode, and sampling time of rats.
| Group | Number | Dose | Administration Mode | Sampling Time |
|---|---|---|---|---|
| NS | 10 | 10 mL/kg | Intragastrically, single-dose | 30 min |
| High dose | 10 | 10 g/kg | Intragastrically, single-dose | 30 min |
| Middle dose | 10 | 5 g/kg | Intragastrically, single-dose | 30 min |
| Low dose | 10 | 2 g/kg | Intragastrically, single-dose | 30 min |